Insights & Expertise Throughout the Drug Development Process

Discover our expert insights on sterile pharmaceuticals, clinical development, regulatory requirements, and current industry trends. Our videos offer you a look into various topics throughout the development process.

CDMO Insights

Scaling a lyophilization cycle: From lab- to commercial-scale processes

Considerations that should be taken into account when transferring a lyophilization process from the laboratory scale to a larger production environment.

Freeze-Drying Sterile Injectables: How Lyophilization Works

How lyophilization stabilizes sterile pharmaceuticals and the advantages it offers for sensitive drug substances.

Sterile Injectables: What they are and how they are manufactured

A concise overview of the importance of sterile injectables, their delivery systems, and the fundamental principles of manufacturing in accordance with pharmaceutical quality and safety standards.

GMP vs cGMP: What they are and how they differ

What are "Good Manufacturing Practices" (GMP) and how do they differ from "current Good Manufacturing Practices" (cGMP)?

5 tips to select the right primary container for your drug product

Here's what you should consider when choosing the appropriate primary packaging material for your parenteral drug.

How to turn a drug substance into a drug product

How your drug substance is transformed into a launchable, sterile drug product.

Leveraging pharma consultants | CDMO Insights

How consultants can support your development projects to efficiently overcome common challenges during clinical studies.

cGMP for your Clinical Batch | CDMO Insights

Dr. Gerhard Reuter explains why early cGMP planning is crucial and how it can reduce time, costs and risks.

Creating a Product Stability Strategy | CDMO Insights

Dr. David Brett explains how to establish the right stability concepts for clinical products at an early stage.

Preparing for your Clinical Batch | CDMO Insights

Garath Duffy provides valuable insights into the key preparatory steps for the first clinical batch.

Fill/finish advances from a CDMO perspective -Drug Solutions Podcast meets Vetter

An expert discussion on Annex 1 developments, market dynamics, and strategic fill‑and‑finish partnerships.

Drug development | The next frontier for CDMO's | Vetter 

Why complex biologics place new demands on development partners — and how CDMOs are responding.